Health care market structures | Nursing homework help
The health care market can be divided into four different market structures: perfect competition, monopolistic competition, oligopoly, and monopoly.
Perfect Competition: Perfect competition is a market structure in which there are many small firms competing with each other to produce the same product or service at the same price. In this market structure, firms have no pricing power and are unable to differentiate their products from competitors. It is typically seen in markets where services are undifferentiated and have low barriers to entry, such as primary care providers.
Monopolistic Competition: Monopolistic competition is similar to perfect competition but involves firms that offer similar but slightly differentiated products or services at different prices. These companies may use unique branding strategies or advertising techniques to stand out from the crowd and attract customers away from their rivals. This type of market structure often exists in medical specialty areas such as cardiology or radiology.
Oligopoly: An oligopoly is a market structure where a few large firms dominate the industry. They are able to control prices by setting them high enough so they can still make profits without pricing themselves out of the market completely. There are also strict regulations in place that limit new entrants into the industry and enable existing players to remain competitive against one another while still making money for shareholders over time. Examples of oligopolies within healthcare include pharmacy benefit managers (PBMs) and health insurance companies who dominate large segments of the health insurance sector due to their size and resources available for lobbying efforts at both state and federal levels.
Monopoly: A monopoly is an extreme form of an oligopoly whereby only one firm dominates an entire industry with little or no competition from other businesses offering similar goods or services—a classic case being pharmaceuticals whose patents give them exclusive rights over certain compounds for years at a time until those patents expire, allowing more generic versionsto enter the marketplace carrying much lower prices than before.